echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Science Translational Medicine: COVID-19 patients should beware of cardiomyocyte damage

    Science Translational Medicine: COVID-19 patients should beware of cardiomyocyte damage

    • Last Update: 2021-05-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    COVID-19 is a pandemic disease caused by SARS-CoV-2, which was initially characterized as the major respiratory syndrome.


    COVID-19 medsci.


    The effect of SARS-CoV-2 on heart cells derived from different types of ipsc.


    The effect of SARS-CoV-2 on heart cells derived from different types of ipsc.


     Human induced pluripotent stem cells were exposed to human induced pluripotent stem cells (iPSC) (iPSC) -derived heart cells exposed to SARS-CoV-2 SARS-CoV-2 , infection and effective transcriptome were found And morphological damage characteristics, especially in cardiomyocytes.


     19-COVID COVID-19 in patients with cardiac dysfunction incidence reported in the range of obstacles to reporting the incidence of heart function in patients with a range of 20--50% 20--50% , regardless of the severity of the disease.


    Original source

    sciencemag.


    sciencemag.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.